Status:
ENROLLING_BY_INVITATION
Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations (Phase II)
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Diabetes Mellitus Type II
Hypertension
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to test the effectiveness and implementation process of a culturally and contextually tailored telehealth-based community health workers (CHW) led coaching intervention fo...
Eligibility Criteria
Inclusion
- identified as of South Asian ethnicity
- at least 21 years of age
- a diagnosis of diabetes
- a diagnosis of hypertension
- an uncontrolled BP reading (\>130/80mmHg) in the last 6 months
Exclusion
- under the age of 21
- Women who are pregnant
- Type 1 diabetes or diabetes secondary to other conditions (e.g. steroid-induced, pancreatic insufficiency, or chemotherapy-induced)
- inability to perform unsupervised physical activity
Key Trial Info
Start Date :
November 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2028
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06542939
Start Date
November 11 2024
End Date
February 1 2028
Last Update
November 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016